Tyrosine kinase and phosphatase regulation of slow delayed-rectifier K+ current in guinea-pig ventricular myocytes

Journal of Physiology

Volumn 573, Issue 2, 2006, Pages 469-482

  Missan, Sergey ^a   Linsdell, Paul ^a   McDonald, Terence F ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BISINDOLYLMALEIMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DAIDZEIN; FORSKOLIN; GENISTEIN; GENISTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ORTHOVANADIC ACID; PHOSPHATASE; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; REGULATOR PROTEIN; TYRPHOSTIN A1; TYRPHOSTIN A23; TYRPHOSTIN A25; TYRPHOSTIN A63; UNCLASSIFIED DRUG; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; DELAYED RECTIFIER POTASSIUM CHANNEL; PP3; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; HEART MUSCLE CELL; HEART REPOLARIZATION; HEART VENTRICLE; IC 50; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECORDING; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SLOWLY ACTIVATING DELAYED RECTIFIER POTASSIUM CURRENT; ADULT; ANIMAL EXPERIMENT; ENZYME ACTIVITY; ENZYME INHIBITION; PROTEIN FUNCTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUINEA PIGS; HEART VENTRICLES; ISOFLAVONES; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 33745031347     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.104422     Document Type: Article

References (64)

1. Ahern CA, Zhang JF, Wookalis MJ & Horn R (2005). Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res 96, 991-998.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M & Fukami Y (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595.
3. Alessi DR, Cuenda A, Cohen P, Dudley DT & Saltiel AR (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270, 27489-27494.
4. 2+ channel current by phorbol esters. Am J Physiol 270, H620-H627.
5. Bain J, McLauchlan H, Elliott M & Cohen P (2003). The specificities of protein kinase inhibitors: An update. Biochem J 371, 199-204.
6. Ks suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol 279, H3003-H3011.
7. Blom N, Gammeltoft S & Brunak S (1999). Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294, 1351-1362.
8. - current elicited by beta1 integrin stretch in rabbit ventricular myocytes. J Gen Physiol 124, 273-287.
9. + current by Src tyrosine kinase. J Biol Chem 277, 13673-13681.
10. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T & Hidaka H (1990). Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265, 5267-5272.
11. + current by Src tyrosine kinase. J Biol Chem 277, 13673-13681.
12. Cohen DM (2005). SRC family kinases in cell volume regulation. Am J Physiol Cell Physiol 288, C483-C493.
13. Crepel V, Panenka W, Kelly ME & MacVicar BA (1998). Mitogen-activated protein and tyrosine kinases in the activation of astrocyte volume-activated chloride current. J Neurosci 18, 1196-1206.
14. Davies SP, Reddy H, Caivano M & Cohen P (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351, 95-105.
15. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Gui P, Hill MA & Wilson E (2001). Regulation of ion channels by protein tyrosine phosphorylation. Am J Physiol Heart Circ Physiol 281, H1835-H1862.
16. Du XL, Gao Z, Lau CP, Chiu SW, Tse HF, Baumgarten CM & Li GR (2004). Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: Evidence for dual regulation by Src and EGFR kinases. J Gen Physiol 123, 427-439.
17. K by guanine nucleotides and isoproterenol. Am J Physiol 262, H1298-H1302.
18. Gamper N, Stockand JD & Shapiro MS (2003). Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase. J Neurosci 23, 84-95.
19. Gavi S, Shumay E, Wang HY & Malbon CC (2006). G-protein-coupled receptors and tyrosine kinases: Crossroads in cell signaling and regulation. Trends Endocrinol Metab 17, 48-54.
20. Gazit A, Yaish P, Gilon C & Levitzki A (1989). Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem 32, 2344-2352.
21. Gilman AG (1987). G proteins: Transducers of receptor-generated signals. Annu Rev Biochem 56, 615-649.
22. Habuchi Y, Tanaka H, Furukawa T, Tsujimura Y, Takahashi H & Yoshimura M (1992). Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes. Am J Physiol 262, H345-H354.
23. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA & Connelly PA (1996). Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271, 695-701.
24. + current in mammalian heart involves G proteins. Am J Physiol 257, H818-H823.
25. Hausdorff WP, Pitcher JA, Luttrell DK, Linder ME, Kurose H, Parsons SJ, Caron MG & Lefkowitz RJ (1992). Tyrosine phosphorylation of G protein alpha subunits by pp60c-src. Proc Natl Acad Sci U S A 89, 5720-5724.
26. Ks in guinea-pig isolated ventricular myocytes. Exp Physiol 81, 587-603.
27. Kr, through a reduction in C-type inactivation in guinea-pig ventricular myocytes. J Physiol 522, 391-402.
28. Herzig S & Neumann J (2000). Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 80, 173-210.
29. Holmes TC, Fadool DA & Levitan IB (1996). Tyrosine phosphorylation of the Kv1.3 potassium channel. J Neurosci 16, 1581-1590.
30. 2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 273, 5337-5342.
31. Jespersen T, Rasmussen HB, Grunnet M, Jensen HS, Angelo K, Dupuis DS, Vogel LK, Jorgensen NK, Klaerke DA & Olesen SP (2004). Basolateral localisation of KCNQ1 potassium channels in MDCK cells: Molecular identification of an N-terminal targeting motif. J Cell Sci 117, 4517-4526.
32. Jongbloed RJ, Wilde AA, Geelen JL, Doevendans P, Schaap C, Van Langen I, van Tintelen JP, Cobben JM, Beaufort-Krol GC, Geraedts JP & Smeets HJ (1999). Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat 13, 301-310.
33. k, by isoprenaline in rabbit isolated pacemaker cells. Exp Physiol 85, 27-35.
34. Liu W, Akhand AA, Kato M, Yokoyama I, Miyata T, Kurokawa K, Uchida K & Nakashima I (1999). 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J Cell Sci 112, 2409-2417.
35. 2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells. J Clin Invest 97, 2332-2341.
36. + current by extracellular ATP in guinea-pig ventricular myocytes. Pflugers Arch 437, 635-642.
37. Nichols MR & Morimoto BH (2000). Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins. Mol Pharmacol 57, 738-745.
38. Ogura T, Shuba LM & McDonald TF (1995). Action potentials, ionic currents and cell water in guinea pig ventricular preparations exposed to dimethyl sulfoxide. J Pharmacol Exp Ther 273, 1273-1286.
39. 2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am J Physiol 276, H1724-H1733.
40. Pawson T & Scott JD (1997). Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080.
41. sd by the epidermal growth factor receptor involves phosphorylation. J Biol Chem 271, 6947-6951.
42. - current in rabbit ventricle by Src and EGFR protein tyrosine kinases. Am J Physiol Heart Circ Physiol 288, H2628-H2636.
43. Sadoshima J, Qiu Z, Morgan JP & Izumo S (1996). Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J 15, 5535-5546.
44. Sanguinetti MC (2000). Long QT syndrome: Ionic basis and arrhythmia mechanism in long QT syndrome type 1. J Cardiovasc Electrophysiol 11, 710-712.
45. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96, 195-215.
46. Schrader LA, Birnbaum SG, Nadin BM, Ren Y, Bui D, Anderson AE & Sweatt JD (2006). ERK/MAPK regulates the Kv4.2 potassium channel by direct phosphorylation of the pore-forming subunit. Am J Physiol Cell Physiol 290, C852-861.
47. Shenolikar S & Nairn AC (1991). Protein phosphatases: Recent progress. Adv Second Messenger Phosphoprotein Res 23, 1-121.
48. Swarup G, Cohen S & Garbers DL (1982). Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun 107, 1104-1109.
49. Terrenoire C, Clancy CE, Cormier JW, Sampson KJ & Kass RS (2005). Autonomic control of cardiac action potentials: Role of potassium channel kinetics in response to sympathetic stimulation. Circ Res 96, e25-34.
50. + current in guinea pig heart cells. Am J Physiol 253, H1321-H1324.
51. + current of guinea pig ventricular cells through the activation of protein kinase C. Circ Res 71, 1441-1446.
52. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M et al. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266, 15771-15781.
53. Tranebjaerg L, Bathen J, Tyson J & Bitner-Glindzicz M (1999). Jervell and Lange-Nielsen syndrome: A Norwegian perspective. Am J Med Genet 89, 137-146.
54. q/11 through tyrosine phosphorylation of the alpha subunit. Science 276, 1878-1881.
55. Walsh KB & Kass RS (1988). Regulation of a heart potassium channel by protein kinase A and C. Science 242, 67-69.
56. K by protein kinases A and C. Am J Physiol 261, C1081-C1090.
57. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ et al. (1996). Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12, 17-23.
58. Ward CA & Giles WR (1997). Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 500, 631-642.
59. Washizuka T, Horie M, Obayashi K & Sasayama S (1998). Genistein inhibits slow component delayed-rectifier K currents via a tyrosine kinase-independent pathway. J Mol Cell Cardiol 30, 2577-2590.
60. Wijetunge S, Aalkjaer C, Schachter M & Hughes AD (1992). Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem Biophys Res Commun 189, 1620-1623.
61. f in rabbit sinoatrial node myocytes. Pflugers Arch 434, 509-514.
62. Yazawa K & Kameyama M (1990). Mechanism of receptor-mediated modulation of the delayed outward potassium current in guinea-pig ventricular myocytes. J Physiol 421, 135-150.
63. + channels expressed in HEK293 cells requires basal protein kinase B activity. FEBS Lett 534, 125-132.
64. Zhou YY, Yao JA & Tseng GN (1997). Role of tyrosine kinase activity in cardiac slow delayed rectifier channel modulation by cell swelling. Pflugers Arch 433, 750-757.